Literature DB >> 19374274

Pertussis in infants: how to protect the vulnerable?

Lai-Man R Chuk1, Stephen B Lambert, Meryta L May, Frank H Beard, Theo P Sloots, Christine E Selvey, Michael D Nissen.   

Abstract

In terms of adverse outcomes, infants remain the group most vulnerable to severe pertussis disease. Adult household contact is thought to be the main source of transmission to infants. This study reviews exposure history, vaccination status, admission outcome and quality of discharge coding of hospitalised infants with pertussis at a tertiary paediatric hospital. We identified cases between 1997 and 2006 from 2 sources: hospital discharge coding and positive Bordetella pertussis results from the hospital laboratory database. We assessed the completeness of each of these sources, compared with the dataset of all identified cases. We identified 55 hospitalised infants with pertussis. The 35 cases (64%) less than 3 months of age had greater risk of Intensive Care Unit admission, higher mortality, and were more likely to have parents as an identified source. On admission, only 5 cases (9%) were more than 2 weeks overdue for their previous scheduled pertussis vaccination. Discharge coding was more sensitive for identifying cases than the laboratory database. Nine cases (16%) had incorrect discharge coding. Even infants up to date for pertussis vaccine can have severe disease requiring hospitalisation. Immunising parents planning to have, or who have had, a newborn baby may help to prevent pertussis in infants.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19374274

Source DB:  PubMed          Journal:  Commun Dis Intell Q Rep        ISSN: 1447-4514


  6 in total

1.  Maternal uptake of pertussis cocooning strategy and other pregnancy related recommended immunizations.

Authors:  C Y Wong; N J Thomas; M Clarke; C Boros; J Tuckerman; H S Marshall
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Potential impact of parental Tdap immunization on infant pertussis hospitalizations.

Authors:  Timothy R Peters; Gretchen C Banks; Beverly M Snively; Katherine A Poehling
Journal:  Vaccine       Date:  2012-06-27       Impact factor: 3.641

3.  Pertussis prevalence and its determinants among children with persistent cough in urban Uganda.

Authors:  Vincent Kayina; Samuel Kyobe; Fred A Katabazi; Edgar Kigozi; Moses Okee; Beatrice Odongkara; Harriet M Babikako; Christopher C Whalen; Moses L Joloba; Philippa M Musoke; Ezekiel Mupere
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

4.  Is the current pertussis incidence only the results of testing? A spatial and space-time analysis of pertussis surveillance data using cluster detection methods and geographically weighted regression modelling.

Authors:  Boris Kauhl; Jeanne Heil; Christian J P A Hoebe; Jürgen Schweikart; Thomas Krafft; Nicole H T M Dukers-Muijrers
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

5.  A cross sectional survey of attitudes, awareness and uptake of the parental pertussis booster vaccine as part of a cocooning strategy, Victoria, Australia.

Authors:  Ellen J Donnan; James E Fielding; Stacey L Rowe; Lucinda J Franklin; Hassan Vally
Journal:  BMC Public Health       Date:  2013-07-23       Impact factor: 3.295

6.  Infectious diseases and vaccination strategies: how to protect the "unprotectable"?

Authors:  Elena Bozzola; Mauro Bozzola; Valeria Calcaterra; Salvatore Barberi; Alberto Villani
Journal:  ISRN Prev Med       Date:  2013-04-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.